Access to clinical trials should be the standard. We're building that.
Providers
Participating Clinics
Trusted by leading collaborators
Our Mission
Trial Library is an AI-native platform that integrates clinical research into routine care pathways, activating providers, identifying eligible patients, and navigating them through the trial lifecycle to make access to clinical trials the standard, not the exception.
We partner across the ecosystem, with health systems, biopharma, and payers/employers.
Each step closing the gap in cancer care.
Clinical trials remain among medicine's most underutilized resources — not for lack of options, but for lack of awareness.
Here's how we've spent the past few years changing that.
Trial Library emerges from stealth with $5M led by Lux Capital.
A conviction became a company — that access to clinical trials shouldn't depend on where you're treated or who you are.
The Oncology Institute and Trial Library partner.
Our platform begins identifying eligible patients across TOI’s community oncology network, with navigation support for patients needing to travel.
Provider Decision Support Platform launches in community oncology.
Real-time trial matching reaches oncology providers directly — starting with prostate cancer.
Johnson & Johnson Innovative Medicine expands collaboration with Trial Library.
The Trial Library platform is applied across J&J's oncology clinical development and medical affairs programs — a major signal of biopharma confidence.
642 patient referrals generated through the TOI partnership in one year.
Our strongest published real-world performance result — proof that meaningful access is achievable at scale.
ACS, PCCTC, and Trial Library launch a national Black patient enrollment initiative.
A coordinated push to accelerate the recruitment of Black patients into prostate cancer trials — health equity as active work, not aspiration.
Trial Library embeds across the American Oncology Network.
Deployed across 3 practices and 10 locations in MO, OH, and NC — tens of patients identified for solid tumor trials in the first quarter.
Texas Oncology partners with Trial Library to extend trial access statewide.
One of the largest cancer care practices in the US. Trial navigation is now a standard part of the care conversation across their network.
Karim Damji joins as Chief Product Officer.
Senior product leadership joins to scale a platform built for the complexity of clinical trial access across patients, providers, and sponsors.
Pre-Screening OS launches — streamlining how patients enter the trial pipeline.
Our most ambitious release yet: a purpose-built operating system that reduces friction for every stakeholder from identification to enrollment.
$10M Series A closes — bringing total funding to $17.6M.
Co-led by SemperVirens VC and Next Ventures, with Sanofi Ventures, Lux Capital, Civilization Ventures, How Women Invest, and others. SemperVirens noted that Trial Library is the first tech company to unlock the payer market for clinical trial access.
Backed by the Best.
Supported by the industry leaders shaping the future of clinical development.
